Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

Close up of chemical microscope and medical research equipment in scientific laboratory. Liquid examination tool with glass lens and blood samples in vacutainers on professional desk

More than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma cancer, such as basal cell carcinoma or squamous cell carcinoma. This increased risk can be several hundred times higher than in the general population.

Countering pharma’s expensive gaming of the drug patent system

Previous article

What you should know about the new Alzheimer’s drug

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations